Jonathan Sylvan Williams, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aldosterone | 29 | 2023 | 869 | 3.340 |
Why?
|
| Sodium Chloride, Dietary | 24 | 2024 | 292 | 3.270 |
Why?
|
| Hypertension | 54 | 2024 | 8529 | 2.830 |
Why?
|
| Renin-Angiotensin System | 18 | 2020 | 737 | 2.510 |
Why?
|
| Sodium, Dietary | 14 | 2023 | 425 | 2.250 |
Why?
|
| Blood Pressure | 38 | 2024 | 8472 | 1.830 |
Why?
|
| Angiotensin II | 15 | 2020 | 849 | 1.500 |
Why?
|
| Renin | 17 | 2023 | 640 | 1.280 |
Why?
|
| Vitamin D | 10 | 2018 | 3302 | 0.890 |
Why?
|
| Histone Demethylases | 6 | 2022 | 323 | 0.860 |
Why?
|
| Diet, Sodium-Restricted | 11 | 2023 | 291 | 0.840 |
Why?
|
| Receptors, Mineralocorticoid | 7 | 2021 | 163 | 0.840 |
Why?
|
| Receptors, Calcitriol | 3 | 2012 | 360 | 0.720 |
Why?
|
| Sodium Chloride | 3 | 2023 | 586 | 0.680 |
Why?
|
| Hypertrophy, Left Ventricular | 3 | 2012 | 851 | 0.650 |
Why?
|
| Polymorphism, Single Nucleotide | 20 | 2024 | 15908 | 0.630 |
Why?
|
| Calmodulin-Binding Proteins | 5 | 2021 | 233 | 0.610 |
Why?
|
| Oxidoreductases, N-Demethylating | 3 | 2012 | 109 | 0.580 |
Why?
|
| Insulin Resistance | 9 | 2016 | 3954 | 0.570 |
Why?
|
| Antihypertensive Agents | 6 | 2019 | 2016 | 0.530 |
Why?
|
| Hyperlipidemias | 1 | 2020 | 770 | 0.500 |
Why?
|
| Resistin | 3 | 2016 | 172 | 0.480 |
Why?
|
| Caveolin 1 | 4 | 2020 | 255 | 0.470 |
Why?
|
| Renal Circulation | 3 | 2011 | 291 | 0.450 |
Why?
|
| Calcium | 3 | 2020 | 5717 | 0.430 |
Why?
|
| Second Messenger Systems | 1 | 2013 | 202 | 0.410 |
Why?
|
| Sodium | 6 | 2023 | 1588 | 0.400 |
Why?
|
| Zona Glomerulosa | 4 | 2022 | 87 | 0.390 |
Why?
|
| Spironolactone | 3 | 2016 | 409 | 0.380 |
Why?
|
| Hydroxycholecalciferols | 1 | 2011 | 44 | 0.380 |
Why?
|
| Cholesterol, LDL | 2 | 2020 | 2379 | 0.370 |
Why?
|
| Blood Pressure Determination | 2 | 2019 | 633 | 0.370 |
Why?
|
| Parathyroid Hormone | 2 | 2015 | 1803 | 0.370 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2020 | 3244 | 0.370 |
Why?
|
| Adipokines | 1 | 2012 | 308 | 0.350 |
Why?
|
| Cholecalciferol | 2 | 2012 | 553 | 0.350 |
Why?
|
| Calcifediol | 1 | 2011 | 161 | 0.350 |
Why?
|
| Hormones | 2 | 2014 | 869 | 0.330 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 2 | 2020 | 34 | 0.330 |
Why?
|
| Immediate-Early Proteins | 1 | 2012 | 444 | 0.330 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2011 | 412 | 0.320 |
Why?
|
| American Heart Association | 1 | 2014 | 1039 | 0.320 |
Why?
|
| Circadian Rhythm | 4 | 2023 | 2569 | 0.320 |
Why?
|
| Estrogen Receptor beta | 2 | 2021 | 168 | 0.320 |
Why?
|
| Drug Resistance | 2 | 2012 | 1594 | 0.320 |
Why?
|
| Adiponectin | 2 | 2011 | 1107 | 0.310 |
Why?
|
| Electrocardiography | 3 | 2012 | 6346 | 0.300 |
Why?
|
| Renal Plasma Flow | 2 | 2021 | 27 | 0.290 |
Why?
|
| Lysine | 2 | 2022 | 993 | 0.290 |
Why?
|
| Diabetes Mellitus | 5 | 2019 | 5835 | 0.290 |
Why?
|
| Research Personnel | 1 | 2012 | 588 | 0.280 |
Why?
|
| Obesity | 6 | 2022 | 12933 | 0.280 |
Why?
|
| Cardiovascular Diseases | 10 | 2019 | 15498 | 0.280 |
Why?
|
| Vitamin D Deficiency | 3 | 2012 | 1388 | 0.280 |
Why?
|
| Adrenal Glands | 3 | 2020 | 552 | 0.280 |
Why?
|
| Kidney Diseases | 2 | 2023 | 2090 | 0.280 |
Why?
|
| Cholesterol | 3 | 2020 | 2903 | 0.280 |
Why?
|
| Angiotensinogen | 2 | 2021 | 161 | 0.280 |
Why?
|
| Nerve Tissue Proteins | 5 | 2021 | 4408 | 0.270 |
Why?
|
| Nucleotides | 3 | 2024 | 453 | 0.270 |
Why?
|
| Cardiovascular System | 1 | 2013 | 834 | 0.250 |
Why?
|
| Male | 71 | 2024 | 360358 | 0.250 |
Why?
|
| Merkel Cells | 2 | 2016 | 24 | 0.250 |
Why?
|
| Epigenesis, Genetic | 3 | 2022 | 3794 | 0.250 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2012 | 1517 | 0.250 |
Why?
|
| Body Mass Index | 7 | 2015 | 12943 | 0.250 |
Why?
|
| Middle Aged | 52 | 2024 | 220584 | 0.240 |
Why?
|
| Female | 67 | 2024 | 392148 | 0.240 |
Why?
|
| Polymorphism, Genetic | 5 | 2017 | 4242 | 0.230 |
Why?
|
| Hyperaldosteronism | 2 | 2013 | 247 | 0.230 |
Why?
|
| Humans | 87 | 2024 | 760617 | 0.230 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2024 | 153 | 0.220 |
Why?
|
| Cell Membrane | 1 | 2013 | 3680 | 0.220 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2014 | 3492 | 0.220 |
Why?
|
| Vitamins | 1 | 2012 | 1635 | 0.220 |
Why?
|
| Cardiology | 1 | 2014 | 1656 | 0.210 |
Why?
|
| Dyspepsia | 1 | 2023 | 116 | 0.200 |
Why?
|
| Membrane Proteins | 5 | 2021 | 7847 | 0.200 |
Why?
|
| Captopril | 2 | 2013 | 265 | 0.200 |
Why?
|
| Spouses | 1 | 2005 | 283 | 0.200 |
Why?
|
| Patient-Centered Care | 1 | 2012 | 1418 | 0.200 |
Why?
|
| Adult | 43 | 2024 | 220969 | 0.200 |
Why?
|
| Estrogens | 2 | 2022 | 1521 | 0.190 |
Why?
|
| Myocardial Contraction | 1 | 2006 | 1515 | 0.180 |
Why?
|
| Genotype | 14 | 2024 | 12978 | 0.180 |
Why?
|
| Gene Frequency | 6 | 2016 | 3601 | 0.180 |
Why?
|
| Bereavement | 1 | 2005 | 309 | 0.180 |
Why?
|
| Natriuresis | 1 | 2020 | 105 | 0.170 |
Why?
|
| Sex Factors | 6 | 2024 | 10548 | 0.170 |
Why?
|
| Practice Guidelines as Topic | 2 | 2015 | 7389 | 0.170 |
Why?
|
| Linkage Disequilibrium | 4 | 2012 | 1994 | 0.170 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2020 | 114 | 0.170 |
Why?
|
| Aminopeptidases | 1 | 2019 | 95 | 0.160 |
Why?
|
| Animals | 29 | 2023 | 168201 | 0.160 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2019 | 293 | 0.160 |
Why?
|
| Sleep | 4 | 2023 | 4758 | 0.150 |
Why?
|
| Linear Models | 4 | 2012 | 5866 | 0.150 |
Why?
|
| Insulin | 7 | 2022 | 6593 | 0.150 |
Why?
|
| Homeostasis | 6 | 2016 | 3321 | 0.150 |
Why?
|
| Hypertension, Renal | 2 | 2021 | 135 | 0.150 |
Why?
|
| Thyrotropin | 1 | 2021 | 834 | 0.150 |
Why?
|
| Mice, Knockout | 8 | 2022 | 14389 | 0.150 |
Why?
|
| Alleles | 8 | 2021 | 6861 | 0.150 |
Why?
|
| Receptors, Adrenergic, beta-2 | 2 | 2010 | 217 | 0.140 |
Why?
|
| Aged | 22 | 2021 | 169042 | 0.140 |
Why?
|
| Ectodysplasins | 1 | 2016 | 11 | 0.140 |
Why?
|
| Hypothyroidism | 1 | 2021 | 667 | 0.130 |
Why?
|
| Calcitriol | 1 | 2018 | 296 | 0.130 |
Why?
|
| Wnt1 Protein | 1 | 2016 | 121 | 0.130 |
Why?
|
| Endothelin-1 | 1 | 2017 | 302 | 0.130 |
Why?
|
| Triglycerides | 3 | 2020 | 2459 | 0.130 |
Why?
|
| Kidney Calculi | 1 | 2020 | 463 | 0.130 |
Why?
|
| Mice | 17 | 2023 | 81368 | 0.130 |
Why?
|
| Touch | 2 | 2016 | 309 | 0.130 |
Why?
|
| Fasting | 2 | 2020 | 1603 | 0.130 |
Why?
|
| Kidney | 4 | 2023 | 7045 | 0.120 |
Why?
|
| Dyslipidemias | 2 | 2020 | 868 | 0.120 |
Why?
|
| Sleep Deprivation | 1 | 2022 | 847 | 0.120 |
Why?
|
| Signal Transduction | 10 | 2020 | 23416 | 0.120 |
Why?
|
| Antineoplastic Agents | 2 | 2017 | 13635 | 0.120 |
Why?
|
| Potassium | 4 | 2020 | 1311 | 0.120 |
Why?
|
| Chi-Square Distribution | 2 | 2012 | 3410 | 0.120 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2021 | 2249 | 0.120 |
Why?
|
| Thyroid Gland | 1 | 2021 | 1170 | 0.120 |
Why?
|
| Cross-Sectional Studies | 8 | 2021 | 26049 | 0.110 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2017 | 253 | 0.110 |
Why?
|
| Water-Electrolyte Balance | 1 | 2015 | 325 | 0.110 |
Why?
|
| Infusions, Intravenous | 3 | 2015 | 2214 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2021 | 17878 | 0.110 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2022 | 1080 | 0.100 |
Why?
|
| Sodium-Bicarbonate Symporters | 1 | 2012 | 30 | 0.100 |
Why?
|
| Iodide Peroxidase | 2 | 2021 | 294 | 0.100 |
Why?
|
| Risk Factors | 13 | 2020 | 74115 | 0.100 |
Why?
|
| Follow-Up Studies | 6 | 2020 | 39063 | 0.100 |
Why?
|
| Mineralocorticoids | 1 | 2012 | 37 | 0.100 |
Why?
|
| Age Factors | 5 | 2019 | 18381 | 0.100 |
Why?
|
| Young Adult | 11 | 2021 | 59179 | 0.100 |
Why?
|
| Lipid Metabolism | 2 | 2020 | 1896 | 0.100 |
Why?
|
| Phenotype | 8 | 2014 | 16571 | 0.100 |
Why?
|
| Norepinephrine | 2 | 2011 | 898 | 0.100 |
Why?
|
| Hedgehog Proteins | 1 | 2016 | 768 | 0.100 |
Why?
|
| Wakefulness | 1 | 2018 | 1264 | 0.100 |
Why?
|
| Hemodynamics | 4 | 2021 | 4160 | 0.100 |
Why?
|
| Rats, Wistar | 4 | 2018 | 1848 | 0.090 |
Why?
|
| Genetic Association Studies | 4 | 2017 | 2734 | 0.090 |
Why?
|
| Multivariate Analysis | 4 | 2012 | 12043 | 0.090 |
Why?
|
| Health Plan Implementation | 1 | 2014 | 335 | 0.090 |
Why?
|
| Haplotypes | 3 | 2012 | 2713 | 0.090 |
Why?
|
| Infusions, Parenteral | 1 | 2010 | 397 | 0.090 |
Why?
|
| Nutrigenomics | 1 | 2010 | 24 | 0.090 |
Why?
|
| Cyclic GMP | 1 | 2011 | 395 | 0.090 |
Why?
|
| Cross-Over Studies | 2 | 2006 | 2079 | 0.090 |
Why?
|
| Blood Glucose | 5 | 2019 | 6390 | 0.080 |
Why?
|
| Adipose Tissue | 3 | 2016 | 3309 | 0.080 |
Why?
|
| France | 1 | 2010 | 492 | 0.080 |
Why?
|
| Sphygmomanometers | 1 | 2009 | 19 | 0.080 |
Why?
|
| Prognosis | 5 | 2020 | 29600 | 0.080 |
Why?
|
| Glucose | 2 | 2022 | 4345 | 0.080 |
Why?
|
| Stethoscopes | 1 | 2009 | 30 | 0.080 |
Why?
|
| Vasoconstriction | 1 | 2011 | 592 | 0.080 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2012 | 794 | 0.080 |
Why?
|
| Drug Synergism | 1 | 2012 | 1755 | 0.070 |
Why?
|
| Research Support as Topic | 1 | 2012 | 697 | 0.070 |
Why?
|
| Energy Metabolism | 1 | 2018 | 2878 | 0.070 |
Why?
|
| PPAR gamma | 1 | 2010 | 484 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2023 | 10199 | 0.070 |
Why?
|
| Prospective Studies | 4 | 2023 | 54360 | 0.070 |
Why?
|
| Albuminuria | 2 | 2023 | 655 | 0.070 |
Why?
|
| Cohort Studies | 10 | 2024 | 41457 | 0.070 |
Why?
|
| Adolescent | 9 | 2021 | 88234 | 0.070 |
Why?
|
| Logistic Models | 3 | 2012 | 13245 | 0.070 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2015 | 1723 | 0.070 |
Why?
|
| Double-Blind Method | 1 | 2020 | 12334 | 0.070 |
Why?
|
| Cerebrovascular Circulation | 1 | 2016 | 2726 | 0.060 |
Why?
|
| Diet | 4 | 2018 | 8048 | 0.060 |
Why?
|
| Environment | 1 | 2011 | 1123 | 0.060 |
Why?
|
| Europe | 1 | 2012 | 3413 | 0.060 |
Why?
|
| Models, Animal | 1 | 2011 | 2109 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2016 | 3608 | 0.060 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2011 | 1492 | 0.060 |
Why?
|
| Depression | 1 | 2005 | 8132 | 0.060 |
Why?
|
| Hypokalemia | 1 | 2006 | 153 | 0.060 |
Why?
|
| United States | 5 | 2014 | 72272 | 0.060 |
Why?
|
| Diastole | 1 | 2006 | 781 | 0.060 |
Why?
|
| Risk Assessment | 3 | 2019 | 23972 | 0.060 |
Why?
|
| Obesity, Morbid | 1 | 2015 | 1276 | 0.060 |
Why?
|
| History, 16th Century | 1 | 2003 | 70 | 0.050 |
Why?
|
| Hydrocortisone | 2 | 2012 | 1819 | 0.050 |
Why?
|
| Weight Loss | 1 | 2015 | 2682 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 5 | 2023 | 22115 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2016 | 12758 | 0.050 |
Why?
|
| Thiazolidinediones | 1 | 2006 | 460 | 0.050 |
Why?
|
| Menstrual Cycle | 1 | 2006 | 539 | 0.050 |
Why?
|
| Glucocorticoids | 1 | 2012 | 2160 | 0.050 |
Why?
|
| Nitric Oxide | 1 | 2011 | 2135 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2015 | 5110 | 0.050 |
Why?
|
| Progesterone | 1 | 2006 | 742 | 0.050 |
Why?
|
| Calcium Channels, L-Type | 1 | 2023 | 242 | 0.050 |
Why?
|
| Vasodilation | 1 | 2006 | 962 | 0.050 |
Why?
|
| Time | 1 | 2023 | 545 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2011 | 3206 | 0.050 |
Why?
|
| Societies, Medical | 1 | 2014 | 3900 | 0.050 |
Why?
|
| Immunotherapy | 1 | 2017 | 4642 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2018 | 12142 | 0.050 |
Why?
|
| Amlodipine | 1 | 2021 | 84 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2014 | 15251 | 0.050 |
Why?
|
| History, 19th Century | 1 | 2003 | 718 | 0.040 |
Why?
|
| Thyroid Function Tests | 1 | 2021 | 288 | 0.040 |
Why?
|
| Posture | 1 | 2005 | 956 | 0.040 |
Why?
|
| Hypoglycemic Agents | 2 | 2019 | 3085 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2013 | 10754 | 0.040 |
Why?
|
| Clinical Trials as Topic | 2 | 2021 | 7995 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 5780 | 0.040 |
Why?
|
| Spirituality | 1 | 2005 | 425 | 0.040 |
Why?
|
| Rats | 4 | 2020 | 23717 | 0.040 |
Why?
|
| Vasoconstrictor Agents | 2 | 2013 | 654 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 5319 | 0.040 |
Why?
|
| Genetic Variation | 2 | 2011 | 6561 | 0.040 |
Why?
|
| Italy | 1 | 2020 | 842 | 0.040 |
Why?
|
| Disease Progression | 1 | 2014 | 13495 | 0.040 |
Why?
|
| Calcium, Dietary | 1 | 2020 | 529 | 0.040 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2021 | 701 | 0.040 |
Why?
|
| Endocrinology | 1 | 2003 | 442 | 0.030 |
Why?
|
| Sirolimus | 1 | 2024 | 1533 | 0.030 |
Why?
|
| Aldehyde Reductase | 1 | 2016 | 70 | 0.030 |
Why?
|
| Eating | 1 | 2023 | 1535 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 11874 | 0.030 |
Why?
|
| Glutamate Decarboxylase | 1 | 2017 | 239 | 0.030 |
Why?
|
| Time Factors | 2 | 2022 | 39913 | 0.030 |
Why?
|
| Minerals | 1 | 2018 | 283 | 0.030 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2016 | 94 | 0.030 |
Why?
|
| Molecular Epidemiology | 1 | 2018 | 469 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2014 | 5034 | 0.030 |
Why?
|
| Polysomnography | 1 | 2022 | 1849 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2003 | 2764 | 0.030 |
Why?
|
| Disease Models, Animal | 4 | 2018 | 18221 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2024 | 2057 | 0.030 |
Why?
|
| Social Support | 1 | 2005 | 2174 | 0.030 |
Why?
|
| Vasodilator Agents | 2 | 2011 | 973 | 0.030 |
Why?
|
| Hair Follicle | 1 | 2016 | 211 | 0.030 |
Why?
|
| Rest | 1 | 2018 | 918 | 0.030 |
Why?
|
| Aging | 1 | 2012 | 8699 | 0.030 |
Why?
|
| Hypertriglyceridemia | 1 | 2016 | 293 | 0.030 |
Why?
|
| Neurosecretory Systems | 1 | 2014 | 223 | 0.030 |
Why?
|
| Genetic Markers | 2 | 2011 | 2601 | 0.030 |
Why?
|
| Inflammation | 1 | 2012 | 10760 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 58894 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 13382 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2023 | 5239 | 0.030 |
Why?
|
| Morphogenesis | 1 | 2016 | 741 | 0.030 |
Why?
|
| Potassium, Dietary | 1 | 2012 | 103 | 0.020 |
Why?
|
| Blood Vessels | 1 | 2018 | 1113 | 0.020 |
Why?
|
| Lipoproteins, HDL | 1 | 2016 | 675 | 0.020 |
Why?
|
| Prevalence | 1 | 2009 | 15689 | 0.020 |
Why?
|
| Parathyroid Glands | 1 | 2013 | 518 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2014 | 876 | 0.020 |
Why?
|
| Skin | 2 | 2016 | 4473 | 0.020 |
Why?
|
| Epidermis | 1 | 2014 | 527 | 0.020 |
Why?
|
| Remission Induction | 1 | 2017 | 2391 | 0.020 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2011 | 260 | 0.020 |
Why?
|
| Echocardiography, Doppler | 1 | 2015 | 893 | 0.020 |
Why?
|
| Organ Size | 1 | 2016 | 2252 | 0.020 |
Why?
|
| Metabolome | 1 | 2018 | 987 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2024 | 4935 | 0.020 |
Why?
|
| Guanylate Cyclase | 1 | 2011 | 205 | 0.020 |
Why?
|
| p-Aminohippuric Acid | 1 | 2010 | 36 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2014 | 2561 | 0.020 |
Why?
|
| Diuretics | 1 | 2013 | 611 | 0.020 |
Why?
|
| Fibroblast Growth Factors | 1 | 2016 | 865 | 0.020 |
Why?
|
| Goals | 1 | 2015 | 708 | 0.020 |
Why?
|
| Keratinocytes | 1 | 2014 | 790 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2023 | 80566 | 0.020 |
Why?
|
| Mass Screening | 1 | 2006 | 5424 | 0.020 |
Why?
|
| Ligands | 1 | 2016 | 3268 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 4570 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2017 | 18937 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 2639 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2020 | 3056 | 0.020 |
Why?
|
| Immune System | 1 | 2014 | 791 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2020 | 8166 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2016 | 2661 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2017 | 2115 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2011 | 705 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2015 | 1467 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2020 | 22148 | 0.020 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2011 | 540 | 0.020 |
Why?
|
| Neurogenesis | 1 | 2014 | 862 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3800 | 0.020 |
Why?
|
| Genetics, Medical | 1 | 2010 | 334 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2012 | 1380 | 0.020 |
Why?
|
| Mutation | 3 | 2020 | 30016 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2016 | 2178 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 6305 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2016 | 2554 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 1779 | 0.020 |
Why?
|
| DNA Repair | 1 | 2016 | 2043 | 0.020 |
Why?
|
| Administration, Sublingual | 1 | 2006 | 59 | 0.020 |
Why?
|
| Exons | 1 | 2012 | 2381 | 0.020 |
Why?
|
| Gastric Bypass | 1 | 2015 | 818 | 0.020 |
Why?
|
| Edema | 1 | 2010 | 765 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 2137 | 0.020 |
Why?
|
| Cognition | 1 | 2023 | 6987 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2015 | 2241 | 0.020 |
Why?
|
| Glucose Clamp Technique | 1 | 2006 | 262 | 0.020 |
Why?
|
| Medication Adherence | 1 | 2017 | 2174 | 0.020 |
Why?
|
| Neoplasms | 1 | 2014 | 22131 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2014 | 6074 | 0.020 |
Why?
|
| Aorta, Thoracic | 1 | 2011 | 1096 | 0.020 |
Why?
|
| Nitroglycerin | 1 | 2006 | 329 | 0.020 |
Why?
|
| Cause of Death | 1 | 2015 | 3683 | 0.020 |
Why?
|
| Hyperemia | 1 | 2006 | 221 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 3451 | 0.010 |
Why?
|
| Brachial Artery | 1 | 2006 | 366 | 0.010 |
Why?
|
| Health Status | 1 | 2017 | 4075 | 0.010 |
Why?
|
| Aorta | 1 | 2011 | 2041 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 14591 | 0.010 |
Why?
|
| Reference Values | 1 | 2010 | 4919 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2011 | 6224 | 0.010 |
Why?
|
| Heart Failure | 1 | 2006 | 11669 | 0.010 |
Why?
|
| Quality of Life | 1 | 2023 | 13347 | 0.010 |
Why?
|
| Protein Binding | 1 | 2014 | 9345 | 0.010 |
Why?
|
| Skin Diseases | 1 | 2010 | 1094 | 0.010 |
Why?
|
| Incidence | 1 | 2019 | 21337 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 3705 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2006 | 2925 | 0.010 |
Why?
|
| Liver | 1 | 2016 | 7512 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2010 | 6338 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2012 | 9643 | 0.010 |
Why?
|
| Cholesterol, HDL | 1 | 2006 | 1810 | 0.010 |
Why?
|
| India | 1 | 2006 | 2286 | 0.010 |
Why?
|
| Estradiol | 1 | 2006 | 1937 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2011 | 3548 | 0.010 |
Why?
|
| Myocardium | 1 | 2011 | 4724 | 0.010 |
Why?
|
| DNA | 1 | 2012 | 7196 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2006 | 4845 | 0.010 |
Why?
|
| Models, Biological | 1 | 2014 | 9461 | 0.010 |
Why?
|
| Patient Selection | 1 | 2010 | 4237 | 0.010 |
Why?
|
| Neurons | 1 | 2016 | 9438 | 0.010 |
Why?
|
| Lipids | 1 | 2006 | 3332 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2006 | 4433 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2010 | 12661 | 0.010 |
Why?
|
| Child | 1 | 2007 | 80079 | 0.000 |
Why?
|